Figure 4 Six reviews investigated the effect of liraglutide on ALT, four reviews investigated semaglutide, and two investigated exenatide and dulaglutide separately
Potential Side Effects and Safety Considerations Before starting any peptide stack, it is crucial to consult with a healthcare professional to ensure safety and appropriateness
While GLP-1 receptor agonists were developed to treat type 2 diabetes, many have demonstrated significant weight loss or weight maintenance effects
Combining semaglutide with other GLP-1 agonists, pramlintide, or certain opioids increases GI side effect risk
Nusko G, Schneider B, Schneider I, Wittekind C, Hahn EG (2000) Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study